-transparent.png){kind=logo}
Thermal denaturation of the recombinant human cystatin C, an 8-residue shorter variant (Leu-9 cystatin C), and the W106S mutant were measured using differential scanning calorimetry (DSC). The finding that Leu-9 cystatin C is of similar stability to the full length protein is in accordance with its nearly normal inhibitory activity. The variant W106S cystatin C exhibits a higher melting temperature by 4 degrees than the wild-type protein. This contrasts with its reduced inhibitory activity and represents an example where activity changes are due to local effects and are not correlated to stability. From the ratio between Van't Hoff and calorimetric enthalpies it is judged that recombinant human cystatin C and Leu-9 cystatin C are dimeric prior to thermal unfolding whereas W106S cystatin C is monomeric. Melting temperatures and estimated stabilities for some other members of the cystatin superfamily of the cysteine proteinase inhibitors are presented which have been recorded previously or were collected for this study (chicken cystatin). It is concluded that thermal stability of human cystatin C (Tm = 82 degrees C) is placed in between the more stable human stefin A (Tm = 95 degrees C) and the less stable human stefin B (Tm = 66 degrees C) whereas chicken cystatin behaves as a thermophilic protein, melting above 115 degrees C. To illustrate secondary structure changes, thermal denaturations of the recombinant human cystatin C and of W106S cystatin C were followed by circular dichroism in the far UV. It was found that the change in tertiary structure (revealed by DSC) precedes the major change in secondary structure.
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
August 2004,
European biophysics journal : EBJ,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
March 1997,
Protein science : a publication of the Protein Society,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
September 1996,
FEBS letters,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
August 1988,
FEBS letters,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
December 1973,
The Biochemical journal,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
October 1970,
The Biochemical journal,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
September 1978,
Nature,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
July 1987,
The Journal of biological chemistry,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
June 2014,
Analytical chemistry,
E Zerovnik, and
N Cimerman, and
J Kos, and
V Turk, and
K Lohner
January 2008,
Journal of immunoassay & immunochemistry,
